Geref (Serono Pharma) en es it fr

Geref (Serono Pharma) Brand names, Geref (Serono Pharma) Analogs

Geref (Serono Pharma) Brand Names Mixture

  • No information avaliable

Geref (Serono Pharma) Chemical_Formula

C154H253N45O45S1

Geref (Serono Pharma) RX_link

http://www.rxlist.com/cgi/generic2/sermorelin.htm

Geref (Serono Pharma) fda sheet

Geref (Serono Pharma) msds (material safety sheet)

Geref (Serono Pharma) Synthesis Reference

No information avaliable

Geref (Serono Pharma) Molecular Weight

3487.0

Geref (Serono Pharma) Melting Point

No information avaliable

Geref (Serono Pharma) H2O Solubility

No information avaliable

Geref (Serono Pharma) State

Liquid

Geref (Serono Pharma) LogP

-0.330

Geref (Serono Pharma) Dosage Forms

Solution (IV or Subcutaneous Injection)

Geref (Serono Pharma) Indication

For the treatment of dwarfism, prevention of HIV-induced weight loss

Geref (Serono Pharma) Pharmacology

Sermorelin is used in the treatment of children with growth hormone deficiency or growth failure. Geref increases plasma growth hormone (GH) concentration by stimulating the pituitary gland to release GH. Geref is similar to the full-length native hormone (44 residues) in its ability to stimulate GH secretion in humans.

Geref (Serono Pharma) Absorption

No information avaliable

Geref (Serono Pharma) side effects and Toxicity

No information avaliable

Geref (Serono Pharma) Patient Information

No information avaliable

Geref (Serono Pharma) Organisms Affected

Humans and other mammals